These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. Expression patterns of pituitary adenylate cyclase activating polypeptide and its type I receptor mRNAs in the rat placenta. Koh PO; Kwak SD; Kim HJ; Roh G; Kim JH; Kang SS; Choi WS; Cho GJ Mol Reprod Dev; 2003 Jan; 64(1):27-31. PubMed ID: 12420296 [TBL] [Abstract][Full Text] [Related]
34. Spinal astrocytic activation contributes to both induction and maintenance of pituitary adenylate cyclase-activating polypeptide type 1 receptor-induced long-lasting mechanical allodynia in mice. Yokai M; Kurihara T; Miyata A Mol Pain; 2016; 12():. PubMed ID: 27175011 [TBL] [Abstract][Full Text] [Related]
35. Role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the action of ginsenoside Rh2 against beta-amyloid-induced inhibition of rat brain astrocytes. Shieh PC; Tsao CW; Li JS; Wu HT; Wen YJ; Kou DH; Cheng JT Neurosci Lett; 2008 Mar; 434(1):1-5. PubMed ID: 18313848 [TBL] [Abstract][Full Text] [Related]
36. Progesterone receptor activation mediates LH-induced type-I pituitary adenylate cyclase activating polypeptide receptor (PAC(1)) gene expression in rat granulosa cells. Ko C; Park-Sarge OK Biochem Biophys Res Commun; 2000 Oct; 277(1):270-9. PubMed ID: 11027674 [TBL] [Abstract][Full Text] [Related]
37. Pituitary adenylate cyclase-activating polypeptide type I receptors mediate cyclic AMP-dependent enhancement of neuronal acetylcholine sensitivity. Margiotta JF; Pardi D Mol Pharmacol; 1995 Jul; 48(1):63-71. PubMed ID: 7623776 [TBL] [Abstract][Full Text] [Related]
38. Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Vaudry D; Falluel-Morel A; Bourgault S; Basille M; Burel D; Wurtz O; Fournier A; Chow BK; Hashimoto H; Galas L; Vaudry H Pharmacol Rev; 2009 Sep; 61(3):283-357. PubMed ID: 19805477 [TBL] [Abstract][Full Text] [Related]
39. Distribution of pituitary adenylate cyclase-activating polypeptide and pituitary adenylate cyclase-activating polypeptide type I receptor mRNA in the chicken brain. Peeters K; Gerets HH; Arckens L; Vandesande F J Comp Neurol; 2000 Jul; 423(1):66-82. PubMed ID: 10861537 [TBL] [Abstract][Full Text] [Related]
40. Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects. Atlasz T; Szabadfi K; Kiss P; Racz B; Gallyas F; Tamas A; Gaal V; Marton Z; Gabriel R; Reglodi D Ann N Y Acad Sci; 2010 Jul; 1200():128-39. PubMed ID: 20633141 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]